ArticleOncoTargets and therapy2017

High expression of CIP2A protein is associated with tumor aggressiveness in stage I-III NSCLC and correlates with poor prognosis.

Geqi Cha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.